GSK557296

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Obstetric Labour, PrematurePremature Ejaculation

Phase 1

A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

CompletedNCT00549211

GlaxoSmithKlineObstetric Labour, Premature, Premature Ejaculation

Start: 2007-10-31Target: 42Updated: 2012-03-19

Phase 2

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation

CompletedNCT01021553

GlaxoSmithKlinePremature Ejaculation

Start: 2009-12-23End: 2011-05-05Updated: 2017-09-12

Related Papers

Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose study.

2013-08-1227 citations